Reaction Details Report a problem with these data
Target
Inward rectifier potassium channel 13
Ligand
BDBM50204281
Substrate
n/a
Meas. Tech.
ChEMBL_1627131 (CHEMBL3869652)
IC50
>100000±n/a nM
Citation
Zhu, Y; de Jesus, RK; Tang, H; Walsh, SP; Jiang, J; Gu, X; Teumelsan, N; Shahripour, A; Pio, B; Ding, FX; Ha, S; Priest, BT; Swensen, AM; Alonso-Galicia, M; Felix, JP; Brochu, RM; Bailey, T; Thomas-Fowlkes, B; Zhou, X; Pai, LY; Hampton, C; Hernandez, M; Owens, K; Ehrhart, J; Roy, S; Kaczorowski, GJ; Yang, L; Parmee, ER; Sullivan, K; Garcia, ML; Pasternak, A Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold. Bioorg Med Chem Lett 26:5695-5702 (2016) [PubMed] Article
More Info.:
Target
Name:
Inward rectifier potassium channel 13
Synonyms:
Inward rectifier K(+) channel Kir7.1 | KCJ13_HUMAN | KCNJ13 | Potassium channel, inwardly rectifying subfamily J member 13
Type:
PROTEIN
Mol. Mass.:
40527.12
Organism:
Homo sapiens (Human)
Description:
ChEMBL_105176
Residue:
360
Sequence:
MDSSNCKVIAPLLSQRYRRMVTKDGHSTLQMDGAQRGLAYLRDAWGILMDMRWRWMMLVFSASFVVHWLVFAVLWYVLAEMNGDLELDHDAPPENHTICVKYITSFTAAFSFSLETQLTIGYGTMFPSGDCPSAIALLAIQMLLGLMLEAFITGAFVAKIARPKNRAFSIRFTDTAVVAHMDGKPNLIFQVANTRPSPLTSVRVSAVLYQERENGKLYQTSVDFHLDGISSDECPFFIFPLTYYHSITPSSPLATLLQHENPSHFELVVFLSAMQEGTGEICQRRTSYLPSEIMLHHCFASLLTRGSKGEYQIKMENFDKTVPEFPTPLVSKSPNRTDLDIHINGQSIDNFQISETGLTE